Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
301
Tue, 7/31/2018,
8:30 AM -
10:20 AM
CC-West 213
SPEED: Statistics for Biopharmaceutical Studies — Contributed Speed
Biopharmaceutical Section , Section on Bayesian Statistical Science
Chair(s): Michael M. Hoffman, Princess Margaret Cancer Centre/University of Toronto
Poster Presentations
for this session.
8:35 AM
Probabilistic Modeling of Sleep and Awake States in Alzheimer's Disease
Cici Bauer, Pfizer, Inc ; Charmaine Demanuele, Pfizer, Inc. ; Dmitri Volfson, Pfizer
8:40 AM
Integrative Statistical Analysis Pipeline for RNA-Seq and NanoString with Application to Gene Expression Data of Cancer Patients
Jeea Choi, Novartis Pharmaceuticals ; Catarina D. Campbell, Novartis Institutes for BioMedical Research; Xiaoshan Wang, Novartis Pharmaceuticals; He Wei, Novartis Pharmaceuticals; Robinson Douglas, Novartis Pharmaceuticals; Stephane Wong, Novartis Pharmaceuticals; Bin Fu, Novartis Pharmaceuticals; Rebecca Leary, Novartis Institutes for BioMedical Research; Kavitha Venkatesan, Novartis Institutes for BioMedical Research; Ying A Wang, Novartis Pharmaceuticals
8:45 AM
Bridging Information Between Dose-Response Curves Across Populations in Early Phase Clinical Trials
Moreno Ursino, Inserm DR PA 6
8:50 AM
A Simultaneous PK/PD Model for Muscle Relaxant Using Muscle Twitch Counts
Elizabeth Sigworth ; Matthew S Shotwell, Vanderbilt University
8:55 AM
STEPDOWN TESTING PROCEDURES for DOSE FINDING STUDY with ADAPTIVE DESIGN
Gang Jia, Merck & Co.
9:00 AM
Conditional Power Calculation for the Interim Monitoring of Cluster-Randomized Trials with Interval-Censored Endpoints
Kaitlyn Cook, Harvard University ; Rui Wang, Harvard Pilgrim HealthCare Institute
9:05 AM
Explore Modified Organ Dysfunction Score System to Improve the Prediction of Survival
Grace Zhang, GSK
9:10 AM
Discovering Biomarkers Jointly Modeled with Multiple Efficacy Variables in Early Phase Clinical Trials
Danni Yu, Eli Lilly and Company
9:15 AM
Extended Rank Tests for Analyzing Recurrent Event Data
Qiang Zhao ; Mark Chang, Veristat; Michael LaValley, Boston University; Joseph M. Massaro, Boston University; Bin Zhang, Seqirus; Kathryn Lunetta, Boston University
9:20 AM
A Study in the Use of Unsupervised Random Forest in the Analysis of Data Sets Composed of Categorical Variables/Features
Nelson Lee Afanador, Merck ; Richard Baumgartner, Merck; Dai Feng, Merck
9:30 AM
A Statistical Evaluation of Cardiovascular Measurements Collected via Mobile Health Technology and Traditional Tools
Qinlei Huang, Merck ; Lori Mixson, Merck
9:35 AM
Method for Evaluating Longitudinal Follow-Up Frequency: Application to Dementia Research
Leah Suttner, University of Pennsylvania ; Sharon X Xie, University of Pennsylvania
9:40 AM
Performance Comparison of Post-Hoc Subgroup Search Algorithms for Clinical Trials
Victor Talisa, University of Pittsburgh ; (Joyce) Chung-Chou H. Chang, University of Pittsburgh
9:45 AM
Relationship Between ORR, PFS and OS in Patients Treated with Anti-PD1/PDL1 Therapies
Jiabu Ye, AstraZeneca ; Pralay Mukhopadhyay, Astrazeneca; Xiang Ji, AstraZeneca
9:50 AM
Real-Time Study Milestone Projection in Clinical Trials with Time-To-Event Endpoints
Yanping Liu, Merck & Co. ; Gang Jia, Merck & Co.
9:55 AM
Sensitivity to Infusion and Blood Draw Time Recording Errors in Pharmacokinetic Modeling
Hannah Weeks, Vanderbilt University ; Matthew S Shotwell, Vanderbilt University
10:00 AM
A Testing Paradigm for Earl Biomedical Research with Many Correlated Tests
Robert Montgomery ; Jonathan D Mahnken, University of Kansas Medical Center
